Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexual Violence
ID: 354033Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Rigorously Evaluating Primary Prevention Strategies for Intimate Partner Violence and Sexual Violence" through a cooperative agreement. This initiative aims to support rigorous evaluations of promising practice-based prevention approaches that address intimate partner violence and sexual violence, particularly those implemented by state and local organizations. The funding is critical for building an evidence base for effective prevention strategies, especially for populations at higher risk due to social determinants of health. The total estimated program funding is $6 million, with individual awards ranging from $0 to $500,000, and applications are due by December 2, 2024. For further inquiries, interested applicants can contact Mikel Walters at ncipc_erpo@cdc.gov.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances." This initiative aims to support pilot research focused on developing and testing behavioral implementation strategies for biomedical interventions, such as oral PrEP and condom use, to enhance HIV and STI prevention among disproportionately affected populations, particularly Black and Hispanic men who have sex with men (MSM) who report substance use. The funding, totaling $2.85 million, is intended for a three-year performance period, with two awards expected, each ranging from $350,000 to $475,000. Interested applicants must submit their proposals by February 20, 2025, with the project anticipated to commence on September 1, 2025. For further inquiries, applicants can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.
    Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements" (RFA-DP-25-126) to provide supplemental funding for previously funded Health Promotion and Disease Prevention Research Centers (PRCs). This initiative aims to support high-quality applied research that informs public health practices and addresses major health challenges, including cancer, diabetes, and obesity, in alignment with the Healthy People 2030 objectives. The total estimated funding available is $21,858,000, with up to 12 awards anticipated, and applications must be submitted electronically through Grants.gov by February 28, 2025, with a Letter of Intent due by February 5, 2025. For further inquiries, applicants can contact Natalie J. Darling at ndh6@cdc.gov.
    Strengthening Vaccine-Preventable Disease Prevention and Response
    Active
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Strengthening Vaccine-Preventable Disease Prevention and Response," aimed at enhancing the nation's immunization infrastructure. This cooperative agreement will support the Immunization Services Division (ISD) in implementing critical programs, including Section 317 and the Vaccines for Children (VFC) Program, to improve vaccination coverage and response to public health threats. The initiative is vital for ensuring equitable access to vaccines, particularly for underserved populations, and will focus on seven priority strategies to strengthen program management and enhance vaccination readiness. The estimated total program funding is $2 billion, with 66 awards expected, and interested applicants can reach out to Randi Tolstyk at 770-488-5114 or via email at KKQ9@cdc.gov. Applications must be submitted electronically by March 7, 2025, with awards anticipated by June 27, 2025.
    Changing Health Systems Using Evidence-based interventions to increase Colorectal Cancer Screening
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Changing Health Systems Using Evidence-based Interventions to Increase Colorectal Cancer Screening," aimed at enhancing screening rates among individuals aged 45 to 75, particularly in areas with low screening prevalence. Applicants are required to establish partnerships with health systems and primary care clinics to implement at least three evidence-based interventions (EBIs) that address barriers to screening and improve data collection methods. This initiative is crucial for reducing health disparities related to colorectal cancer and improving public health outcomes. Interested organizations can apply for funding ranging from $350,000 to $900,000, with a total program budget of $110 million, and must submit their applications by February 20, 2025. For further inquiries, contact April Vance at abv8@cdc.gov.
    Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)." This initiative aims to evaluate the effectiveness of existing Community-Clinical Linkage and Social Connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also exploring the mechanisms that influence diabetes outcomes. The program is critical for understanding how these interventions can mitigate health disparities and improve health outcomes in communities. The estimated total funding for this program is $3,150,000, with awards ranging from $0 to $350,000, and applications are due by January 6, 2025. For further inquiries, interested applicants can contact Dr. Celeste Sanders at CSanders4@cdc.gov.
    PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study that evaluates strategies for integrating Postexposure Prophylaxis (PEP) packs into existing Pre-exposure Prophylaxis (PrEP) services, specifically targeting populations disproportionately affected by HIV, such as Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The program seeks to enhance access to nonoccupational PEP (nPEP) and includes the provision of starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits to facilitate immediate prevention following potential exposures. The total funding available for this opportunity is $4.8 million, with a single award anticipated, and applications must be submitted electronically by February 19, 2025. For further inquiries, interested parties can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at implementing combination prevention solutions to control the HIV epidemic among high-risk populations in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to provide targeted interventions, particularly for adolescents aged 10-24, focusing on evidence-based biomedical, behavioral, and structural approaches to reduce new HIV infections and improve health equity. The estimated funding amount for the first year is $25 million, with applications due by February 20, 2025. Interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    RFA-CC-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-CC-18-000, aimed at supporting Type 6 Applications through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with no cost-sharing or matching requirements specified. This funding initiative is categorized under health-related activities, with an expected total of 100 awards available, although the award ceiling and floor are both set at zero. Interested parties should note that the application deadline is October 13, 2025, and may contact Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756 for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.